Intellectual Property India Publishes Patent Application for 'Compound Based On Isoindoline-Substituted Glutarimide Backbone And Use Thereof' Filed by Gluetacs Therapeutics (SHANGHAI) Co. Ltd.

MUMBAI, India, Feb. 21 -- Intellectual Property India has published a patent application (202517008669 A) filed by Gluetacs Therapeutics (SHANGHAI) Co. Ltd., Shanghai, on Feb. 3, for 'compound based on isoindoline-substituted glutarimide backbone and use thereof.'

Inventor(s) include Yang, Xiaobao; Sun, Renhong; Zhou, Yuedong; and Zhao, Baoyin.

The application for the patent was published on Feb. 21, under issue no. 08/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure relates to a compound of formula (I) or a salt thereof, an enantiomer thereof, a stereoisomer thereof, a solvate thereof, or a polymorph thereof, and use thereof. The present disclosure further relates to a pharmaceutical c...